nach oben

Erschienen in:

24.10.2017 | Endocrine Genetics/Epigenetics

A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure

verfasst von: Monica M. França, Mariana F. A. Funari, Antonio M. Lerario, Mirian Y. Nishi, Carmem C. Pita, Eveline G. P. Fontenele, Berenice B. Mendonca

Erschienen in: Endocrine | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Primary ovarian failure (POF) is characterized by amenorrhea, hypoestrogenism, and elevated gonadotropin levels in women leading to infertility under the age of 40 years. POF is a heterogeneous disease with different causes, and several genes have been associated with the POF phenotype. Thus, Whole-exome sequencing (WES) was performed in a consanguineous family with two sisters affected by POF.

Methods

All exons of both sisters were massively sequenced by WES, and the segregation was confirmed by Sanger sequencing.

Results

The novel homozygous c.1489delT variant in the NOBOX gene was identified in the two sisters with POF. Their parents were heterozygous carriers of this variant and, therefore, consistent with an autosomal recessive mode of inheritance. The c.1489delT NOBOX variant has not been previously reported in any public available databases (1000Genomes, 6500ESP/EVS, ExAC, and gnomAD). Furthermore, this variant was neither present in 387 Brazilian exomes control individuals nor in 200 fertile Brazilian women screened by Sanger sequencing.

Conclusion

We report the first familial case of a novel homozygous NOBOX variant with an autosomal recessive mode of inheritance, thus allowing for a genetic diagnosis of primary ovarian failure.

A.N. Shelling, Premature ovarian failure. Reprod. Rev. 140, 633–641 (2010). https://doi.org/10.1530/REP-09-0567 CrossRef

E.J. Tucker, S.R. Grover, A. Bachelot, P. Touraine, A.H. Sinclair, Premature ovarian insufficiency: new perspectives on genetic cause and phenotypic spectrum. Endocr. Rev. 37(6), 609–635 (2016). https://doi.org/10.1210/er.2016-1047 CrossRefPubMed

N. Suzumori, C. Yan, M.M. Matzuk, A. Rajkovic, Nobox is a homeobox-encoding gene preferentially expressed in promordial and growing oocytes. Mech. Dev. 111(1–2), 137–141 (2002). https://doi.org/10.1016/S0925-4773(01)00620-7CrossRefPubMed

R. Rossetti, I. Ferrari, M. Bonomi, L. Persani, Genetics of primary ovarian insufficiency. Clin. Genet. 91(2), 183–198 (2017). https://doi.org/10.1111/cge.12921 CrossRefPubMed

L. Li, B. Wang, W. Zhang, B. Chen, M. Luo, J. Wang, X. Wang, Y. Cao, K. Kee, A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency. Hum. Reprod. 32(1), 248–255 (2017). https://doi.org/10.1093/humrep/dew271 PubMed

H. Li, R. Durbin, Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26(5), 589–595 (2010). https://doi.org/10.1093/bioinformatics/btp698 CrossRefPubMedPubMedCentral

G. Tischler, S. Leonard, Biobambam: tools for read pair collation based algorithms on BAM files. Source Code Biol. Med. 9, 13 (2014). https://github.com/gt1/biobambam2/releases CrossRefPubMedCentral

K. Okonechnikov, A. Conesa, F. García-Alcalde, Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data. Bioinformatics. 32(2), 292–294 (2016). https://doi.org/10.1093/bioinformatics/btv566 PubMed

A. Garrison, G. Marth, Haplotype-based variant detection from short-read sequencing, (2012). https://arxiv.org/abs/1207.3907

10.

J.M. Alvarez-Castro, R.C. Yang, R.C. Multiallelic, models of genetic effects and variance decomposition in non-equilibrium populations. Genetics 139(9), 1119–1134 (2011). https://doi.org/10.1007/s10709-011-9614-9

11.

K. Wang, M. Li, H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high- throughput sequencing data. Nucl. Acid. Res. 38(16), e164 (2010). https://doi.org/10.1093/nar/gkq603 CrossRef

12.

M. Lek, K.J. Karczewski, E.V. MiniKel et al. Exome aggregation consortium: analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616), 285–291 (2016). https://doi.org/10.1038/nature15393 CrossRefPubMedPubMedCentral

13.

Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL:http://evs.gs.washington.edu/EVS/)

14.

The 1000 Genomes Project Consortium : a global reference for human genetic variation. Nature 526, 68–74 (2015). https://doi.org/10.1038/nature15393 CrossRefPubMedCentral

15.

A. Rajkovic, S.A. Pangas, D. Ballow, N. Suzumori, M.M. Matzuk, NOBOX deficiency disrupts early folliculogenesis and oocytes-specific gene expression. Science 305(5687), 1157–1159 (2004). https://doi.org/10.1126/science.1099755 CrossRefPubMed

16.

A. Lechowska, S. Bilinski, Y. Choi, Y. Shin, M. Kloc, A. Rajkovic, Premature ovarian failure in nobox-deficient mice is caused by defects in somatic cell invasion and germ cell cyst breakdown. J. Assist. Reprod. Genet. 28(7), 583–589 (2011). https://doi.org/10.1007/s10815-011-9553-5 CrossRefPubMedPubMedCentral

17.

Y. Qin, Y. Choi, H. Zhao, J.L. Simpson, Z.I. Chen, A. Rajkovic, NOBOX homeobox mutation causes premature ovarian failure. Am. J. Hum. Genet. 81(3), 576–581 (2007). https://doi.org/10.1086/519496 CrossRefPubMedPubMedCentral

18.

J. Bouilly, A. Bachelot, I. Broutin, P. Touraine, N. Binart, Novel NOBOX loss-of-function mutations accountfor 6.2% of cases in a large primary ovarian insufficiency cohort. Hum. Mutat. 32(10), 1108–1113 (2011). https://doi.org/10.1002/humu.21543 CrossRefPubMed

19.

J. Bouilly, F. Roucher-Boulez, A. Gompel, H. Bry-Gauillard, K. Azibi, C. Beldjord, C. Dodé, J. Bouligand, A.G. Mantel, A.C. Hécart, B. Delemer, J. Young, N. Binart, New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression. J. Clin. Endocrinol. Metab. 100(3), 994–1001 (2015). https://doi.org/10.1210/jc.2014-2761 CrossRefPubMed

20.

N. Bouali, B. Francou, J. Bouligand, B. Lakhal, I. Malek, M. Kammoun, J. Warszawski, S. Mougou, A. Saad, A. Guiochon-Mantel, NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency. Clin. Genet. 89(5), 608–613 (2016). https://doi.org/10.1111/cge.12750 CrossRefPubMed

21.

I. Ferrari, J. Bouilly, I. Beau, F. Guizzardi, A. Ferlin, M. Pollazzon, M. Salerno, N. Binart, L. Persani, R. Rossetti, Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiency. Hum. Mol. Genet. 25(23), 5223–5233 (2016). https://doi.org/10.1093/hmg/ddw342 PubMed

22.

Y. Qin, Y. Shi, Y. Zhao, S.A. Carson, J.I. Simpson, Z.J. Chen, Mutation analysis of NOBOX homeodomain in chinese women with premature ovarian failure. Fertil. Steril. 91(Suppl.4), 1507–1509 (2009). https://doi.org/10.1016/j.fertnstert.2008.08.020 CrossRefPubMed

23.

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, ACMG Laboratory Quality Assurance Committee, standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology.Genet. Med. 17(5), 405–424 (2015) https://doi.org/10.1038/gim.2015.30 CrossRefPubMedPubMedCentral

24.

J.C. Achermann, M. Ito, M. Ito, P.C. Hindmarsh, J.L. Jameson, A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22(2), 125–126 (1999). https://doi.org/10.1038/9626 CrossRefPubMed

25.

J.C. Achermann, G. Ozisik, M. Ito, U.A. Orun, K. Harmanci, B. Gurakan, J.L. Jameson, Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1 in dose-dependent manner. J. Clin. Endocrinol. Metab. 87(4), 1829–1833 (2002). https://doi.org/10.1210/jcem.87.4.8376. CrossRefPubMed

Titel: A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure
verfasst von: Monica M. França
Mariana F. A. Funari
Antonio M. Lerario
Mirian Y. Nishi
Carmem C. Pita
Eveline G. P. Fontenele
Berenice B. Mendonca
Publikationsdatum: 24.10.2017
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-017-1459-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Nierenkarzinom | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure

Abstract

Purpose

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series

Specific plasma amino acid disturbances associated with metabolic syndrome

Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience

Heritability of Addison’s disease and prevalence of associated autoimmunity in a cohort of 112,100 Swedish twins

Thyroid reoperation using intraoperative neuromonitoring

Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Update Innere Medizin